ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.25
+0.34 (5.75%)
At close: Jan 30, 2026, 4:00 PM EST
6.27
+0.02 (0.32%)
After-hours: Jan 30, 2026, 7:59 PM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $6.16 billion as of January 30, 2026. Its market cap has increased by 252.76% in one year.
Market Cap
6.16B
Enterprise Value
6.76B
1-Year Change
252.76%
Ranking
Category
Stock Price
$6.25
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $6.16B, a decrease of -58.47%. That is a compound annual growth rate of -16.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.16B | 215.66% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | 14.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 7.01B |
| Rhythm Pharmaceuticals | 6.84B |
| Caris Life Sciences | 6.53B |
| Belite Bio | 6.34B |
| Mirum Pharmaceuticals | 6.18B |
| Structure Therapeutics | 6.12B |
| PTC Therapeutics | 6.06B |
| Kymera Therapeutics | 5.82B |